scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH · Real-Time Price · USD
4.850
+0.280 (6.13%)
Aug 22, 2025, 4:00 PM - Market closed
scPharmaceuticals Market Cap
scPharmaceuticals has a market cap or net worth of $258.50 million as of August 22, 2025. Its market cap has increased by 64.06% in one year.
Market Cap
258.50M
Enterprise Value
269.85M
1-Year Change
64.06%
Ranking
Category
Stock Price
$4.85
Market Cap Chart
Since November 17, 2017, scPharmaceuticals's market cap has increased from $248.30M to $258.50M, an increase of 4.11%. That is a compound annual growth rate of 0.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 243.57M | 37.50% |
| Dec 31, 2024 | 177.14M | -21.22% |
| Dec 29, 2023 | 224.85M | -7.91% |
| Dec 30, 2022 | 244.17M | 77.80% |
| Dec 31, 2021 | 137.32M | -4.98% |
| Dec 31, 2020 | 144.53M | 37.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 17, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |